Functional Neuromodulation gets FDA breakthrough device status for Vercise DBS system
Functional Neuromodulation has secured breakthrough device designation from the US Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) for Vercise deep